Skip to main content

Table 1 Clinical characteristics of study population (n = 272)

From: Polypharmacy and adverse outcomes after hip fracture surgery

Parameter Mean/proportion Std. deviation Minimum Maximum
Age, years 82.0 9.0 53 100
Gender, n, % females 196
72.1
   
P-Glucose admission, mmol/L 7.5 2.1 3.4 19.8
P-Glucose, 3rd day, mmol/L 9.0 3.2 5.7 16.9
P-Sodium admission, mmol/L 138.7 3.4 125.0 147.0
P-Sodium 3rd day, mmol/L 137.0 3.5 120.0 146.0
P-Potassium admission, mmol/L 3.9 0.5 2.6 5.9
P-Potassium 3rd day, mmol/L 3.7 0.5 2.4 5.5
P-Creatinine admission, μmol/L 88.5 48.6 26.0 563.0
P-Creatinine 3rd day, μmol/L 91.2 67.4 34.0 614.0
P-Hemoglobin admission, g/L 122.7 15.7 74.0 192.0
P-Hemoglobin 3rd day, g/L 106.2 13.1 72.0 143.0
Blood pressure-systolic admission, mmHg 144 22 90 220
Blood pressure-systolic 3rd day, mmHg 121 18 70 180
Blood pressure-diastolic admission, mmHg 75 12 50 120
Blood pressure-diastolic 3rd day, mmHg 63 10 40 100
No. of medications, admission 6.2 3.9 0.0 20.0
No. of medications, discharge 7.8 3.6 0.0 20.0
  1. Glucose, sodium, potassium, and creatinine were plasma levels